Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2021 | The impact of antibiotic use on ICI treatment in mUC

Shilpa Gupta, MD, Cleveland Clinic, Cleveland, OH, gives an outline of the effect of antibiotic use after initiation of immune checkpoint inhibitor (ICI) treatment on overall survival (OS) in patients with metastatic urothelial carcinoma (mUC). Dr Gupta reports that antibiotic use within 30 days of initiation of ICI treatment did not impact OS, despite other reports suggesting a negative outcome from the two treatments. This interview took place during the 2021 Genitourinary Cancers Symposium.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.